Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, UK.
Open Biol. 2022 Sep;12(9):220134. doi: 10.1098/rsob.220134. Epub 2022 Sep 7.
Aurora Kinase A (AURKA) is a positive regulator of mitosis with a strict cell cycle-dependent expression pattern. Recently, novel oncogenic roles of AURKA have been uncovered that are independent of the kinase activity and act within multiple signalling pathways, including cell proliferation, survival and cancer stem cell phenotypes. For this, cellular abundance of AURKA protein is crucial and must be tightly fine-tuned. Indeed, AURKA is found overexpressed in different cancers, typically as a result of gene amplification or enhanced transcription. It has however become clear that impaired processing, decay and translation of AURKA mRNA can also offer the basis for altered AURKA levels. Accordingly, the involvement of gene expression mechanisms controlling AURKA expression in human diseases is increasingly recognized and calls for much more research. Here, we explore and create an integrated view of the molecular processes regulating AURKA expression at the level of transcription, post-transcription and translation, intercalating discussion on how impaired regulation underlies disease. Given that targeting AURKA levels might affect more functions compared to inhibiting the kinase activity, deeper understanding of its gene expression may aid the design of alternative and therapeutically more successful ways of suppressing the AURKA oncogene.
极光激酶 A(AURKA)是有丝分裂的正调控因子,具有严格的细胞周期依赖性表达模式。最近,发现了 AURKA 的新致癌作用,这些作用独立于激酶活性,并作用于多个信号通路,包括细胞增殖、存活和癌症干细胞表型。为此,AURKA 蛋白的细胞丰度至关重要,必须进行严格的微调。事实上,AURKA 在不同的癌症中过度表达,通常是由于基因扩增或转录增强。然而,人们已经清楚地认识到,AURKA mRNA 的加工、降解和翻译受损也可能为 AURKA 水平的改变提供基础。因此,越来越多的人认识到控制 AURKA 表达的基因表达机制参与人类疾病,并呼吁进行更多的研究。在这里,我们探讨并创建了一个在转录、转录后和翻译水平上调节 AURKA 表达的分子过程的综合视图,穿插讨论了调节失常如何导致疾病。鉴于与抑制激酶活性相比,靶向 AURKA 水平可能会影响更多的功能,因此更深入地了解其基因表达可能有助于设计替代的、更成功的抑制 AURKA 癌基因的治疗方法。